Nanostructured lipid carriers as oral delivery systems for poorly soluble drugs

被引:66
|
作者
Beloqui, Ana [1 ]
del Pozo-Rodriguez, Ana [2 ]
Isla, Arantxazu [2 ]
Rodriguez-Gascon, Alicia [2 ]
Angeles Solinis, Maria [2 ]
机构
[1] Catholic Univ Louvain, Louvain Drug Res Inst, Adv Drug Delivery & Biomat, B-1200 Brussels, Belgium
[2] Univ Basque Country, Pharmacokinet Nanotechnol & Gene Therapy Grp Phar, Fac Pharm, UPV EHU,Lascaray Res Ctr, Paseo Univ 7, Vitoria 01006, Spain
关键词
Nanostructured lipid carriers; Poor water soluble drugs; Oral drug delivery; Bioavailability; Hot high-pressure homogenization; Inflammatory bowel diseases; OF-THE-ART; BIOAVAILABILITY ENHANCEMENT; IN-VIVO; PHYSICOCHEMICAL CHARACTERIZATION; FORMULATION DEVELOPMENT; GASTROINTESTINAL MUCUS; INTESTINAL BARRIER; NANOPARTICLES SLN; LIPOPHILIC DRUGS; PHARMACOKINETICS;
D O I
10.1016/j.jddst.2017.06.013
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Poorly water soluble (PWS) drugs lack from good oral absorption, which limits their oral administration, the most common drug delivery route. The design of appropriate innovative formulations for PWS drugs will allow for adequate bioavailability, reduction of the required dose and oral delivery of drugs that would otherwise need the parenteral route. Among the formulations under study, Nanostructured Lipid Carriers (NLCs), made of biocompatible mixtures of solid and liquid lipids, represent a good choice. NLCs enhance the apparent solubility and dissolution of PWS drugs in the gastrointestinal tract, and/or modulate the drug permeability and fate across the intestinal barrier, opening new perspectives in the field of innovative medicines for oral administration of PWS molecules. Recently, NLCs have also emerged as a promising anti-inflammatory drug delivery system for inflammatory bowel diseases. The present paper is focused on the state of the art of NLCs for oral delivery of PWS drugs. The design, the main preparation techniques and the mechanisms through the drug oral delivery is improved by NLCs are presented, highlighting the influence of the most relevant technological and formulation factors on the properties of the NLCs, which condition their efficacy as oral delivery formulations. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:144 / 154
页数:11
相关论文
共 50 条
  • [21] In Vivo Precipitation of Poorly Soluble Drugs from Lipid-Based Drug Delivery Systems
    Sassene, P. J.
    Michaelsen, M. H.
    Mosgaard, M. D.
    Jensen, M. K.
    Van Den Broek, E.
    Wasan, K. M.
    Mu, H.
    Rades, T.
    Mullertz, A.
    MOLECULAR PHARMACEUTICS, 2016, 13 (10) : 3417 - 3426
  • [22] Silica-lipid hybrid (SLH) microcapsules: A novel oral delivery system for poorly soluble drugs
    Tan, Angel
    Simovic, Spomenka
    Davey, Andrew K.
    Rades, Thomas
    Prestidge, Clive A.
    JOURNAL OF CONTROLLED RELEASE, 2009, 134 (01) : 62 - 70
  • [23] Solid lipid nanoparticles and nanostructured lipid carriers in oral cancer drug delivery
    Nasirizadeh, Samira
    Malaekeh-Nikouei, Bizhan
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2020, 55
  • [24] A novel strategy for encapsulating poorly soluble drug into nanostructured lipid carriers for intravenous administration
    Zhao, Chunyan
    Liu, Yan
    Fan, Tingting
    Zhou, Dan
    Yang, Yang
    Jin, Yun
    Zhang, Zhirong
    Huang, Yuan
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2012, 17 (04) : 443 - 456
  • [25] Formulation of lipid bearing pellets as a delivery system for poorly soluble drugs
    Chopra, Shruti
    Venkatesan, Natarajan
    Betageri, Guru V.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2013, 446 (1-2) : 136 - 144
  • [26] Role of phospholipids in the oral and parenteral delivery of poorly water soluble drugs
    van Hoogevest, P.
    Liu, X.
    Fahr, A.
    Leigh, M. L. S.
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2011, 21 (01) : 5 - 16
  • [27] Tocol modified glycol chitosan for the oral delivery of poorly soluble drugs
    Duhem, Nicolas
    Rolland, Julien
    Riva, Raphael
    Guillet, Pierre
    Schumers, Jean-Marc
    Jerome, Christine
    Gohy, Jean-Francois
    Preat, Veronique
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2012, 423 (02) : 452 - 460
  • [28] Novel amphiphilic polyethylenimine (PEIs) for oral delivery of poorly soluble drugs
    Cheng, W. P.
    Uchegbu, I. F.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2004, 56 : S34 - S35
  • [29] Potential of ordered mesoporous silica for oral delivery of poorly soluble drugs
    Vialpando, Monica
    Martens, Johan A.
    Van den Mooter, Guy
    THERAPEUTIC DELIVERY, 2011, 2 (08) : 1079 - 1091
  • [30] Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs
    Dahan, Arik
    Hoffman, Amnon
    JOURNAL OF CONTROLLED RELEASE, 2008, 129 (01) : 1 - 10